Press Releases Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-15 pm EDT			5-day change	1st Jan Change
3.956 ^USD	+4.09%		+0.78%	+14.65%

May. 09	Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	May. 13	AQ
Xenetic Biosciences : Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K	May. 10	PU
Xenetic Biosciences: Q1 Earnings Snapshot	May. 09	AQ
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results	Mar. 25	AQ
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K	Mar. 22	PU
Xenetic Biosciences: Q3 Earnings Snapshot	Nov. 10	AQ
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference	23-10-12	AQ
Xenetic Biosciences: Q2 Earnings Snapshot	23-08-11	AQ
Xenetic Biosciences: Q1 Earnings Snapshot	23-05-11	AQ
XENETIC BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
Xenetic Biosciences : Reports Full Year 2022 Financial Results and Provides Business Update - Form 8-K	23-03-23	PU
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-22	AQ
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-22	AQ
XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-09	AQ
XENETIC BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-12-02	AQ
Xenetic Biosciences: Q3 Earnings Snapshot	22-11-10	AQ
Xenetic Biosciences : Reports Third Quarter 2022 Financial Results and Provides Business Update - Form 8-K	22-11-10	PU
XENETIC BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-09	AQ
Xenetic Biosciences : Private Placement - Form 8-K	22-10-12	PU
XENETIC BIOSCIENCES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-10-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Press Releases

Filters